Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 28, 2013Cancer Discovery

First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement

View Full Paper
Ask AI
Bookmark
Share

Authors

Josep TaberneroJosep TaberneroUniversity College DublinGeoffrey I. ShapiroGeoffrey I. ShapiroBroad InstitutePLPatricia LoRussoYale Cancer Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tabernero et al. (2013) studied this question.

synapsesocial.com/papers/69d7370bf07a12db70b8a5b3https://doi.org/10.1158/2159-8290.cd-12-0429
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality <i>in vivo</i> imaging2007 · 794 citations
  2. 2Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study2011 · 325 citations
  3. 3Inhibiting the VEGF–VEGFR pathway in angiosarcoma, epithelioid hemangioendothelioma, and hemangiopericytoma/solitary fibrous tumor2010 · 170 citations